Medical Marijuana Inc (OTCMKTS:MJNA) has announced that it has decided to invest in Axim Biotechnologies. The company stated that this was done to bring more diversity to the company’s growing investment portfolio. Additionally, the company has launched new peppermint dew drops, through its subsidiary Dixie Botanicals. The subsidiary is well known in the marijuana industry for producing quality CBD hemp oil products. Additionally, the company also comprises of top formulation experts, who work to manufacture a variety of products from CBD hemp oils.
MJNA CEO, Stuart Titus, stated that his company has acquired an ownership interest in the biotech company. He also pointed out that Axim has recently been working on hemp-based innovations, which caught his company’s interests. George E. Anastassov, CEO of Axim, stated that his company focuses on biotech innovations, while keeping in mind environmental protection and conservation. Additionally, the company tends to target areas where there are no feasible solutions.
MJNA itself is a company focused on marijuana based innovations, but concentrates more on edible products. This innovation is reflected on the company’s launch of the new dew drops. Dixie Botanicals aims to bridge the gap between mainstream and cannabis consumer markets. The subsidiary has been showcasing its products in trade shows, natural product expos and private entrepreneurs as well. MJNA makes use of its proprietary cultivars for the production and supply of the hemp plant to its subsidiaries. Dixie Botanicals makes use of only the mature plants from the produce.
Additionally, MJNA has recently been bestowed another honor, with regard to its cannabis based products. ProVerde Labs tested a number of MJNA products for quality assurance and found them to be top notch and clean for human consumption. It is important to note here that ProVerde is considered one of the leading quality testing labs in the world.
Medical Marijuana Inc (OTCMKTS:MJNA) finished the July 1 trading session with a decline of 8.57% in share value, to close at $0.064 after trading 1.84 million shares in the market.
